CTMX - CytomX Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CTMX is currently covered by 9 analysts with an average price target of $12.69. This is a potential upside of $10.35 (442.31%) from yesterday's end of day stock price of $2.34.

CytomX Therapeutics's activity chart (see below) currently has 95 price targets and 95 ratings on display. The stock rating distribution of CTMX is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.58% with an average time for these price targets to be met of 122.94 days.

Highest price target for CTMX is $17, Lowest price target is $6.5, average price target is $12.69.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 13-Aug-2026.

Best performing analysts who are covering CTMX - CytomX Therapeutics:

Christopher Marai Mitchell Kapoor Etzer Darout Peter Lawson Joseph Catanzaro Mohit Bansal

Currently out of the existing stock ratings of CTMX, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Aug-2026

$11

$8.66 (370.09%)

$12

2 months 18 days ago
(13-Aug-2026)

0/4 (0%)

$7.65 (228.36%)

Buy Since 09-Mar-2026

$14

$11.66 (498.29%)

$15

2 months 21 days ago
(10-Aug-2026)

0/4 (0%)

$10.56 (306.98%)

Buy Since 20-May-2025

$11

$8.66 (370.09%)

$10

5 months 20 days ago
(11-May-2026)

2/4 (50%)

$7.14 (184.97%)

244

Buy Since 10-Nov-2025

$12

$9.66 (412.82%)

$10

7 months 8 days ago
(23-Mar-2026)

1/3 (33.33%)

$7.54 (169.06%)

126

Buy Since 08-Nov-2024

$12

$8.6 (252.94%)

$10

7 months 8 days ago
(23-Mar-2026)

4/9 (44.44%)

$7.54 (169.06%)

219

Show more analysts

Please expand the browser size to see the chart

What is CTMX (CytomX Therapeutics) average time for price targets to be met?

On average it took 123 days for the stock forecasts to be reached, with an average price target met ratio of 31.58%.

Which analyst most recently updated their price target on CTMX (CytomX Therapeutics)?

Anupam Rama

Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?

Anupam Rama works at JPMORGAN and has 34 price targets and 20 ratings on CTMX

Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?

Varun Kumar with the highest potential upside of $20.66

Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?

Mara Goldstein with the lowest potential downside of -$0.34
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?